INADA Hideki | Department of Cardiovascular Medicine, Hypertension and Cardiorenal Medicine, Dokkyo University Scho

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Urinary excretion of liver fatty acid-binding protein in health-check participants
Nipradilol Prevents L-NAME-Exacerbated Nephrosclerosis with Decreasing of Caspase-3 Expression in SHR
Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension
Incidence of cardiovascular diseases and angiotensin-converting enzyme gene polymorphism in chronic hemodialysis patients
Relations of Blood Pressure Values to the Risks of Death and Cardiovascular Events in Chronic Hemodialysis Patients(Hypertension, Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Effects of Valsartan on the Progression of Chronic Renal Insufficiency in Patients with Nondiabetic Renal Diseases
Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients
Relation of CYP11B2 Gene Polymorphism to the Incidence of Cardiovascular Diseases in Chronic Hemodialysis Patients
OJ-248 Losartan Reduced Massive Proteinuria in Chronic Renal Disease Patients with Lower Renal Tissue TGF-beta1 mRNA Levels(Hypertension, Clinical 5 (H) : OJ29)(Oral Presentation (Japanese))
Valsartan reduced cardiac fibrosis by caspase-3 activation and TGF-β reduction in L-NAME/SHR in vivo
Effects of Efonidipine, an L- and T-type Calcium Channel Blocker, on the Renin-Angiotensin-Aldosterone System in Chronic Hemodialysis Patients

もっと見る

スポンサーリンク